TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8822354

Group type: EXPERIMENTAL
Intervention: Bone Mineral Density (BMD) measurements at the spine
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Prior history of fracture
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Family history of hip fracture (maternal grandmother)
Number of subjects: 1857

Group type: EXPERIMENTAL
Intervention: Postmenopausal status or having a hysterectomy
Number of subjects: 1857
Study: 1446443

Group type: EXPERIMENTAL
Intervention: Tension band wiring (TBW)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Plate fixation (PF)
Number of subjects: 41
Study: 2937224

Group type: COMPARATOR
Intervention: Streptokinase
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Streptokinase and PTCA
Number of subjects: 127
Study: 31257951

Group type: EXPERIMENTAL
Intervention: Moisture barrier #1
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control
Number of subjects: 20
Study: 29967006

Group type: EXPERIMENTAL
Intervention: Anodal stimulation (tDCS)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo (sham controls)
Number of subjects: 81
Study: 27686226

Group type: EXPERIMENTAL
Intervention: 50 mg mirabegron once daily
Number of subjects: 89

Group type: COMPARATOR
Intervention: 0.1 mg imidafenacin twice daily
Number of subjects: 89
Study: 24096138

Group type: EXPERIMENTAL
Intervention: Aerobic exercise (n=13)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sedentary attention control (n=9)
Number of subjects: 22
Study: 22853865

Group type: EXPERIMENTAL
Intervention: Fesoterodine SR 4 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Fesoterodine SR 8 mg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 20164809

Group type: EXPERIMENTAL
Intervention: n-3 fatty acids (N3) - 2000 mg eicosapentaenoic acid and 400 mg docosahexaenoic acid
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vitamin-mineral complex (VM) - vitamins C (2000 mg), E (800 IU), A (3000 IU), selenium (200 microg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Vitamin-mineral complex and n-3 fatty acid combination (VN3)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 48
Study: 17914135

Group type: EXPERIMENTAL
Intervention: Low vitamin D stores (18 ng/ml)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Adequate vitamin D stores (>34 ng/ml)
Number of subjects: 69
Study: 16076305

Group type: EXPERIMENTAL
Intervention: Modified D. pteronyssinus extract
Number of subjects: 55
Study: 12120773

Group type: EXPERIMENTAL
Intervention: Hand excavation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Bur excavation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Air-abrasion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Sono-abrasion
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Laser ablation
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Chemomechanical methods
Number of subjects: 36
Study: 10204750

Group type: EXPERIMENTAL
Intervention: Rating Scale (RS)
Number of subjects: 281

Group type: EXPERIMENTAL
Intervention: Standard Gamble (SG)
Number of subjects: 281
Study: 7779152

Group type: EXPERIMENTAL
Intervention: 200 mg aciclovir tablet (test formulation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 200 mg aciclovir tablet (reference formulation)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 400 mg aciclovir tablet (test formulation)
Number of subjects: 24

Group type: COMPARATOR
Intervention: 400 mg aciclovir tablet (reference formulation)
Number of subjects: 24
Study: 2095841

Group type: EXPERIMENTAL
Intervention: Figurative version of the story 'Peaches the Cat'
Number of subjects: 14

Group type: COMPARATOR
Intervention: Literal version of the story 'Peaches the Cat'
Number of subjects: 14
Study: 30699446

Group type: EXPERIMENTAL
Intervention: PCDT with anticoagulation
Number of subjects: 300
Study: 29381110

Group type: EXPERIMENTAL
Intervention: Flurbiprofen 8.75 mg
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122
Study: 26368321

Group type: EXPERIMENTAL
Intervention: Lumbar puncture (LP)
Number of subjects: 3868

Group type: EXPERIMENTAL
Intervention: Risk factors for PLPH
Number of subjects: 3868

Group type: COMPARATOR
Intervention: Other factors
Number of subjects: 3868
Study: 24524293

Group type: EXPERIMENTAL
Intervention: Early childhood obesity prevention intervention with a parent modelling component
Number of subjects: 460
Study: 21457411

Group type: EXPERIMENTAL
Intervention: Multifaceted transitional care intervention including home-based exercise strategies
Number of subjects: 128

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 128
Study: 20195151

Group type: EXPERIMENTAL
Intervention: SNB plus complete axillary dissection (AD arm)
Number of subjects: 516

Group type: COMPARATOR
Intervention: SNB with axillary dissection only if the sentinel node contained metastases (SN arm)
Number of subjects: 516
Study: 17881538

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha‐2a 135 microg subcutaneously once per week
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard interferon alpha‐2a 3 million units subcutaneously thrice per week
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Pegylated interferon alpha‐2a
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard interferon alpha‐2a
Number of subjects: 50
Study: 15633704

Group type: EXPERIMENTAL
Intervention: Nine executive function tasks (seven commonly used in clinical practice)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Statistically driven analyses and SEM
Number of subjects: 122
Study: 12658471

Group type: EXPERIMENTAL
Intervention: Eptifibatide plus heparin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Heparin alone
Number of subjects: 100
Study: 10338168

Group type: EXPERIMENTAL
Intervention: Hypertonic saline plus hyaluronidase
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 83

Group type: COMPARATOR
Intervention: Isotonic saline (0.9% NaCl)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Isotonic saline plus hyaluronidase
Number of subjects: 83
Study: 8901210

Group type: EXPERIMENTAL
Intervention: Music played at 70 dBA
Number of subjects: 90

Group type: COMPARATOR
Intervention: Music played at 60 dBA
Number of subjects: 90

Group type: COMPARATOR
Intervention: Music played at 80 dBA
Number of subjects: 90
Study: 1959887

Group type: EXPERIMENTAL
Intervention: Colchicine (0.6 mg twice daily)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 6313561

Group type: EXPERIMENTAL
Intervention: Hemibody radiation (HBI)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Systemic chemotherapy
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Hemibody radiation (HBI) as a consolidating-maintenance agent
Number of subjects: 65
Study: 31343010

Group type: EXPERIMENTAL
Intervention: α-lipoic acid (α-LA) supplementation (1200 mg/day, 600 mg per capsule, 2 capsules daily)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo capsules (2 capsules daily)
Number of subjects: 50
Study: 28891772

Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy plus Hypnosis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Attention Control
Number of subjects: 100
Study: 26934084

Group type: EXPERIMENTAL
Intervention: Watermelon extract (6 g daily for 42 days)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Control group (mixture of carbohydrates: sucrose/glucose/fructose)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Watermelon extract (6 g daily for 42 days) in carriers of the T allele (MTHFR C677T)
Number of subjects: 43
Study: 25475463

Group type: EXPERIMENTAL
Intervention: GA/TEE protocol
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Awake TAVR protocol
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Rapid discharge group
Number of subjects: 144

Group type: COMPARATOR
Intervention: Standard discharge
Number of subjects: 144
Study: 23082849

Group type: EXPERIMENTAL
Intervention: Total Disc Replacement (TDR) with ProDisc-L
Number of subjects: 236

Group type: COMPARATOR
Intervention: Circumferential Fusion
Number of subjects: 236
Study: 19497646

Group type: EXPERIMENTAL
Intervention: Olive oil-based lipid emulsion (OO)
Number of subjects: 28

Group type: COMPARATOR
Intervention: MCT/LCT lipid emulsion (M/L)
Number of subjects: 28
Study: 17495205

Group type: EXPERIMENTAL
Intervention: Binge Eating Disorder (BED) diagnosis
Number of subjects: 845

Group type: EXPERIMENTAL
Intervention: Night Eating Syndrome (NES) diagnosis
Number of subjects: 845

Group type: EXPERIMENTAL
Intervention: Participants with eating disorders
Number of subjects: 845
Study: 14630619

Group type: EXPERIMENTAL
Intervention: Sitaxsentan 300 mg
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Sitaxsentan 100 mg
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178
Study: 11781553

Group type: EXPERIMENTAL
Intervention: 0.5 mg atropine intravenously (i.v.)
Number of subjects: 39

Group type: COMPARATOR
Intervention: No medication (control group)
Number of subjects: 39
Study: 9767282

Group type: EXPERIMENTAL
Intervention: VML295
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7522392

Group type: EXPERIMENTAL
Intervention: Thick, energy-dense porridge (4.09 kJ/g)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Traditional liquid, low-density porridge (2.15 kJ/g)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Amylase-treated thick energy-dense porridge
Number of subjects: 15
Study: 2673340

Group type: EXPERIMENTAL
Intervention: 150 mg ethinyloestradiol gel
Number of subjects: 25

Group type: COMPARATOR
Intervention: gel alone (control)
Number of subjects: 25
Study: 29703576

Group type: EXPERIMENTAL
Intervention: Heart rate characteristics (HRC) monitoring
Number of subjects: 3

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 3
Study: 28342705

Group type: EXPERIMENTAL
Intervention: 20% mannitol (5ml/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: 3% hypertonic saline (5.35ml/kg)
Number of subjects: 40
Study: 26124205

Group type: EXPERIMENTAL
Intervention: Cardiac Resynchronization Therapy with defibrillator backup (CRT-D)
Number of subjects: 1281

Group type: COMPARATOR
Intervention: Implantable cardioverter-defibrillator only (ICD)
Number of subjects: 1281
Study: 22612365

Group type: EXPERIMENTAL
Intervention: periosteum with alloplastic graft material
Number of subjects: 20

Group type: COMPARATOR
Intervention: periosteum alone
Number of subjects: 20
Study: 21186071

Group type: EXPERIMENTAL
Intervention: Assessment of urinary Gb3 using electrospray ionization tandem mass spectrometry
Number of subjects: 28
Study: 18316562

Group type: EXPERIMENTAL
Intervention: PC + bevacizumab (BPC arm)
Number of subjects: 878

Group type: COMPARATOR
Intervention: PC arm
Number of subjects: 878
Study: 16179584

Group type: EXPERIMENTAL
Intervention: Spironolactone (25 mg/d)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Eplerenone (200 mg.kg(‐1).d(‐1))
Number of subjects: 10

Group type: COMPARATOR
Intervention: Aldosterone (250 nmol/L)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Eplerenone (2 micromol/L)
Number of subjects: 10
Study: 11874386

Group type: EXPERIMENTAL
Intervention: Alosetron (2 mg, single oral and intravenous doses)
Number of subjects: 48
Study: 9892590

Group type: EXPERIMENTAL
Intervention: 192Ir
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 7770253

Group type: EXPERIMENTAL
Intervention: Trial of labor
Number of subjects: 9

Group type: COMPARATOR
Intervention: Elective cesarean
Number of subjects: 9
Study: 2202512

Group type: EXPERIMENTAL
Intervention: Ceftizoxime 2 gm intravenously every 12 hours with doxycycline 100 mg intravenously twice daily (Rx 1)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Cefoxitin 2 gm intravenously every six hours with doxycycline 100 mg intravenously twice daily (Rx 2)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Ceftizoxime 2 gm intravenously every eight hours with doxycycline 100 mg intravenously twice daily (Rx 3)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Clindamycin 900 mg intravenously every eight hours with a 2‐mg/kg loading dose of gentamicin followed by 1.5 mg/kg intravenously every eight hours (Rx 4)
Number of subjects: 67
Study: 6813604

Group type: EXPERIMENTAL
Intervention: Family member reinforcement
Number of subjects: 402

Group type: COMPARATOR
Intervention: Triage method for health education interventions
Number of subjects: 402
Study: 31776695

Group type: EXPERIMENTAL
Intervention: New Zealand blackcurrant extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31532808

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Missing work to come to the CHC
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Absence of depressive symptoms
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Told by someone important to come to the CHC
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Shorter distance to the treatment site
Number of subjects: 505
Study: 28592069

Group type: EXPERIMENTAL
Intervention: Mobile application education and follow-up
Number of subjects: 132

Group type: COMPARATOR
Intervention: Traditional education (face-to-face and telephone)
Number of subjects: 132
Study: 26486166

Group type: EXPERIMENTAL
Intervention: Ezetimibe/Simvastatin 10/20 mg (ES10/20)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Statin dose-doubling (to S40 or A20)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Rosuvastatin 10 mg (R10)
Number of subjects: 358
Study: 23628600

Group type: EXPERIMENTAL
Intervention: Tanezumab 10mg
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Tanezumab 20mg
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Tanezumab 5mg
Number of subjects: 1347

Group type: EXPERIMENTAL
Intervention: Naproxen 500mg
Number of subjects: 1347

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1347
Study: 21554401

Group type: EXPERIMENTAL
Intervention: DFX-40 (deferasirox 40 mg/kg/d for 6 months)
Number of subjects: 38

Group type: COMPARATOR
Intervention: DFX-20 (deferasirox 20 mg/kg/d for 6 months)
Number of subjects: 38

Group type: COMPARATOR
Intervention: β-TM patients
Number of subjects: 38
Study: 19842461

Group type: EXPERIMENTAL
Intervention: Lifestyle physical activity intervention (LIFE)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 68
Study: 17174223

Group type: EXPERIMENTAL
Intervention: Homozygosity for the 379V allele
Number of subjects: 123
Study: 15095048

Group type: EXPERIMENTAL
Intervention: Unilateral carotid endarterectomy (CE)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Surgically untreated uni-/bilateral carotid stenosis (CS)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 35
Study: 12630983

Group type: EXPERIMENTAL
Intervention: Triamcinolone acetonide (TA) 220 micro g
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Mometasone furoate (MF) 200 micro g
Number of subjects: 27

Group type: COMPARATOR
Intervention: Triamcinolone acetonide (TA) vs Mometasone furoate (MF)
Number of subjects: 27
Study: 9427571

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (non-SK)
Number of subjects: 31
Study: 10150709

Group type: EXPERIMENTAL
Intervention: Patients interpreting the term 'rare' in relation to death
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients interpreting the term 'rare' in relation to severe heart attack
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients interpreting the term 'rare' in relation to severe pneumonia
Number of subjects: 0
Study: 3262857

Group type: EXPERIMENTAL
Intervention: PRP vaccine
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: PRP-D vaccine
Number of subjects: 69
Study: 31332020

Group type: EXPERIMENTAL
Intervention: selinexor plus low-dose dexamethasone
Number of subjects: 0
Study: 28712786

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT) for 12 months
Number of subjects: 398
Study: 25444717

Group type: EXPERIMENTAL
Intervention: FC2
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Woman's Condom
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Cupid
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: VA w.o.w
Number of subjects: 300
Study: 22545978

Group type: EXPERIMENTAL
Intervention: Online self-monitoring
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Patterns of consistent self‐monitoring
Number of subjects: 161
Study: 21633086

Group type: EXPERIMENTAL
Intervention: Continued transfusions
Number of subjects: 79

Group type: COMPARATOR
Intervention: Transfusion-halted group
Number of subjects: 79
Study: 20088413

Group type: EXPERIMENTAL
Intervention: Nuchal acupuncture and abdominal acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine acupuncture
Number of subjects: 60
Study: 16245263

Group type: EXPERIMENTAL
Intervention: Metoclopramide (30 mg)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 15329362

Group type: EXPERIMENTAL
Intervention: Lactobacillus F19 with penicillin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lactobacillus F19 with ciprofloxacin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo with penicillin
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo with ciprofloxacin
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Lactobacillus F19
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 10649153

Group type: EXPERIMENTAL
Intervention: Modified Burch procedure
Number of subjects: 36

Group type: COMPARATOR
Intervention: Suburethral sling
Number of subjects: 36
Study: 9286225

Group type: EXPERIMENTAL
Intervention: Guar gum (5 g) with water (300 ml)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Guar gum (5 g) with glucose drink (300 ml/330 kcal)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Guar gum (5 g) with solid meal (530 kcal)
Number of subjects: 12
Study: 8364350

Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg or 60 mg daily
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Fluoxetine 60 mg daily
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: Fluoxetine (any dose)
Number of subjects: 214

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study: 3108527

Group type: EXPERIMENTAL
Intervention: CS-514 5 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: CS-514 20 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: CS-514 40 mg
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: CS-514 (all doses)
Number of subjects: 41
Study: 29189215

Group type: EXPERIMENTAL
Intervention: Lateral transperitoneal adrenalectomy (LTA)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Posterior retroperitoneoscopic adrenalectomy (PRA)
Number of subjects: 83
Study: 28449303

Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: BI + group CBT
Number of subjects: 214

Group type: EXPERIMENTAL
Intervention: BI + group PE
Number of subjects: 214

Group type: COMPARATOR
Intervention: BI alone
Number of subjects: 214
Study: 26596801

Group type: EXPERIMENTAL
Intervention: Intraperitoneal implantation of sustained-release 5-fluorouracil 600 mg as local chemotherapy
Number of subjects: 202
Study: 23332619

Group type: EXPERIMENTAL
Intervention: Doxycycline 40 mg capsules orally once daily for 16 weeks
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo 40 mg capsules orally once daily for 16 weeks
Number of subjects: 34
Study: 21172396

Group type: EXPERIMENTAL
Intervention: Black tea
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tea
Number of subjects: 0
Study: 19825728

Group type: EXPERIMENTAL
Intervention: Adductor tendon transfer (group 1)
Number of subjects: 31

Group type: COMPARATOR
Intervention: No adductor tendon transfer (group 2)
Number of subjects: 31
Study: 21092029

Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion during aortic cross‐clamping (Group P)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonpulsatile perfusion (Group NP)
Number of subjects: 30
Study: 16282544

Group type: EXPERIMENTAL
Intervention: CADASIL patients
Number of subjects: 14

Group type: COMPARATOR
Intervention: Healthy age-matched control subjects
Number of subjects: 14
Study: 12192015

Group type: COMPARATOR
Intervention: Stenting
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 220
Study: 9726738

Group type: EXPERIMENTAL
Intervention: Colchicine/prednisone (n=19)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: D-penicillamine/prednisone (n=11)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: D-penicillamine/colchicine/prednisone (n=11)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Prednisone alone (n=15)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 56
Study: 7979607

Group type: EXPERIMENTAL
Intervention: PGG-glucan
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 34
Study: 2656042

Group type: EXPERIMENTAL
Intervention: MAb 96.5 followed by ZME-018
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MAb ZME-018 followed by 96.5
Number of subjects: 17

Group type: COMPARATOR
Intervention: Each MAb followed by itself (controls)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MAb 96.5 as first infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: MAb 96.5 as second infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: ZME-018 as first infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: ZME-018 as second infusion
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Toxicity related to HAMA response
Number of subjects: 17
Study: 1117249

Group type: EXPERIMENTAL
Intervention: Modeling procedures complemented by the appropriate rule statement
Number of subjects: 40

Group type: COMPARATOR
Intervention: Modeling procedures alone
Number of subjects: 40
Study: 31067356

Group type: EXPERIMENTAL
Intervention: Irinotecan with vincristine (VI) followed by multi-agent chemotherapy for 44 weeks
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Multi-agent chemotherapy including tirapazamine (TPZ) for 31 weeks
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Multi-agent chemotherapy without VI and TPZ for 31 weeks
Number of subjects: 136
Study: 26565071

Group type: EXPERIMENTAL
Intervention: Tacrolimus
Number of subjects: 557

Group type: COMPARATOR
Intervention: Ciclosporin-A (CsA-ME)
Number of subjects: 557